secwatch.observer — SEC 8-K summary
======================================

Issuer:     China Health Industries Holdings, Inc. (—)
CIK:        0001309057
Form:       8-K
Filed at:   2023-12-04T23:59:59+00:00
Accession:  0001213900-23-092414
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

China Health Industries closes acquisition of HempCan for ~$40.9M
-----------------------------------------------------------------

- Closed acquisition of 100% of Heilongjiang HempCan Pharmaceuticals on Dec 1, 2023.
- Total cash consideration of RMB295M (~$40.9M) paid to sellers Xin Sun and Kai Sun.
- Transaction was previously announced in Form 8-K filed July 3, 2023.
- Humankind, a wholly owned subsidiary, is the acquiring entity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1309057/000121390023092414/0001213900-23-092414-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1309057/000121390023092414/ea189444-8k_chinahealth.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-092414

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer